PMC:7281546 / 55733-55959 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T120","span":{"begin":76,"end":79},"obj":"Disease"}],"attributes":[{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0010565"}],"text":"nsp1 type I IFNs and type III IFN antagonists; inducing the degradation of CBP; suppression of phosphorylation and degradation of IκBα, as well as p65 nuclear translocation; blocking nuclear translocation of IRF1 [65,78,130]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T523","span":{"begin":13,"end":30},"obj":"http://purl.obolibrary.org/obo/PR_000024990"},{"id":"T524","span":{"begin":133,"end":134},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"nsp1 type I IFNs and type III IFN antagonists; inducing the degradation of CBP; suppression of phosphorylation and degradation of IκBα, as well as p65 nuclear translocation; blocking nuclear translocation of IRF1 [65,78,130]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43488","span":{"begin":35,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A19326","pred":"chebi_id","subj":"T43488","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"}],"text":"nsp1 type I IFNs and type III IFN antagonists; inducing the degradation of CBP; suppression of phosphorylation and degradation of IκBα, as well as p65 nuclear translocation; blocking nuclear translocation of IRF1 [65,78,130]"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T445","span":{"begin":61,"end":72},"obj":"http://purl.obolibrary.org/obo/GO_0009056"},{"id":"T446","span":{"begin":96,"end":111},"obj":"http://purl.obolibrary.org/obo/GO_0016310"},{"id":"T447","span":{"begin":116,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0009056"}],"text":"nsp1 type I IFNs and type III IFN antagonists; inducing the degradation of CBP; suppression of phosphorylation and degradation of IκBα, as well as p65 nuclear translocation; blocking nuclear translocation of IRF1 [65,78,130]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T426","span":{"begin":0,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nsp1 type I IFNs and type III IFN antagonists; inducing the degradation of CBP; suppression of phosphorylation and degradation of IκBα, as well as p65 nuclear translocation; blocking nuclear translocation of IRF1 [65,78,130]"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2556","span":{"begin":31,"end":34},"obj":"Gene"},{"id":"2557","span":{"begin":76,"end":79},"obj":"Gene"},{"id":"2558","span":{"begin":131,"end":135},"obj":"Gene"},{"id":"2559","span":{"begin":148,"end":151},"obj":"Gene"},{"id":"2560","span":{"begin":209,"end":213},"obj":"Gene"},{"id":"2574","span":{"begin":0,"end":4},"obj":"Gene"}],"attributes":[{"id":"A2556","pred":"tao:has_database_id","subj":"2556","obj":"Gene:3439"},{"id":"A2557","pred":"tao:has_database_id","subj":"2557","obj":"Gene:1387"},{"id":"A2558","pred":"tao:has_database_id","subj":"2558","obj":"Gene:4792"},{"id":"A2559","pred":"tao:has_database_id","subj":"2559","obj":"Gene:5970"},{"id":"A2560","pred":"tao:has_database_id","subj":"2560","obj":"Gene:3659"},{"id":"A2574","pred":"tao:has_database_id","subj":"2574","obj":"Gene:10045"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nsp1 type I IFNs and type III IFN antagonists; inducing the degradation of CBP; suppression of phosphorylation and degradation of IκBα, as well as p65 nuclear translocation; blocking nuclear translocation of IRF1 [65,78,130]"}